🇺🇸 FDA
Patent

US 11266699

Synergistic bacterial compositions and methods of production and use thereof

granted A61KA61K2035/11A61K2035/115

Quick answer

US patent 11266699 (Synergistic bacterial compositions and methods of production and use thereof) held by Seres Therapeutics, Inc. expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Seres Therapeutics, Inc.
Grant date
Tue Mar 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2035/11, A61K2035/115, A61K35/74, A61K35/742